(Q39465974)

12 September 2017

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals (English)

1 reference

12 September 2017

0 references

congestive heart failure

1 reference

Philbin EF

1

1 reference

12 September 2017

Andreaou C

2

1 reference

12 September 2017

Rocco TA

3

1 reference

12 September 2017

Lynch LJ

4

1 reference

12 September 2017

Baker SL

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

American Journal of Cardiology

12 September 2017

1 reference

12 September 2017

77

1 reference

12 September 2017

10

1 reference

12 September 2017

832-838

1 reference

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Comparison of captopril and enalapril in patients with severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Tolerability of enalapril in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Perspective of the pharmaceutical industry on the development of new drugs for heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Trends in hospitalization for heart failure in Scotland 1980-1990.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Acute heart failure: determinants of outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Predictors of mortality in patients with heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989177-1

10.1016/S0002-9149(97)89177-1

7 January 2021

Identifiers

DOI

1 reference

release_uekqjq2iabbqxh6pj2opsdgi5e

12 September 2017

0 references

1 reference